What they were paid
REGENERON PHARMACEUTICALS Director Compensation Table · all 5 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $107,411 | $119,415 | $480,552 | $10,449 | $717,827 |
| FY2024 | $100,000 | $119,926 | $479,846 | $0 | $699,772 |
| FY2023 | $100,000 | $119,772 | $480,215 | $5,000 | $704,987 |
| FY2022 | $100,000 | $119,490 | $480,539 | $5,000 | $705,029 |
| FY2021 | $100,000 | $119,705 | $480,389 | $5,000 | $705,094 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: REGENERON PHARMACEUTICALS, INC. DEF 14A filed April 24, 2026, accession 0001308179-26-000340, and prior-year filings. Open the filing on EDGAR.
How this page was built: the REGENERON PHARMACEUTICALS, INC. filed document, accession 0001308179-26-000340. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2026.
Get the REGENERON PHARMACEUTICALS Board Governance Report
$717,827 N. Anthony Coles, FY2025 total director compensation
$500
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of April 24, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2025REGENERON PHARMACEUTICALS pays directors a $90,000 cash retainer and $600,000 in Stock Options (80%) and RSUs (20%).
Committees
FY2025 · as the proxy prints themAudit · Compensation
The rest of the REGENERON PHARMACEUTICALS board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Arthur F. Ryan | Independent Director | $725,416 |
| Bonnie L. Bassler | Independent Director | $715,416 |
| Christine A. Poon | Lead Independent Director | $775,416 |
| Craig B. Thompson | Independent Director | $705,170 |
| David P. Schenkein | Independent Director | $704,565 |
| George D. Yancopoulos | Director | — |
| George L. Sing | Independent Director | $730,416 |
| Huda Y. Zoghbi | Independent Director | $720,416 |
| Joseph L. Goldstein | Independent Director | $715,416 |
| Kathryn Guarini | Independent Director | $701,544 |
| Leonard S. Schleifer | Director | — |
| Michael S. Brown | Independent Director | $730,416 |
The full REGENERON PHARMACEUTICALS compensation record
free company briefThis page is one director within REGENERON PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.
Peer companies
named in the REGENERON PHARMACEUTICALS proxy · each links to its own free briefOrder REGN
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.